Merck's full-year 2025 revenue guidance fell short of what some analysts were expecting, at a range of $64.1 billion to $65.6 ...
During his second day of confirmation hearings, Robert F. Kennedy Jr. declined to disavow comments he had made disparaging ...
Shares of Merck are sliding in early trading after the drugmaker surprised Wall Street with a lower-than-expected 2025 sales ...
Merck & Co Inc (NYSE:MRK) reported fourth-quarter sales of $15.62 billion, up 7% year over year and slightly beating the ...
Robert F. Kennedy Jr. also disclosed that he had reached at least one settlement agreement with a company or individual that has accused him of “misconduct or inappropriate behavior.” ...
A new vaccine for kidney cancer shows excellent preliminary results. All patients on the trial had no evidence of cancer ...
Robert F. Kennedy Jr. says he won't collect fees from litigation against the drugmakers of a cervical cancer vaccine if he's ...
President Donald Trump’s pick for secretary of Health and Human Services said he will divest his interest in lawsuits against ...